These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 8234341)
1. Cloning and pharmacological characterization of a rat kappa opioid receptor. Meng F; Xie GX; Thompson RC; Mansour A; Goldstein A; Watson SJ; Akil H Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9954-8. PubMed ID: 8234341 [TBL] [Abstract][Full Text] [Related]
2. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754 [TBL] [Abstract][Full Text] [Related]
3. Cloning and expression of a cDNA for the rat kappa-opioid receptor. Minami M; Toya T; Katao Y; Maekawa K; Nakamura S; Onogi T; Kaneko S; Satoh M FEBS Lett; 1993 Aug; 329(3):291-5. PubMed ID: 8103466 [TBL] [Abstract][Full Text] [Related]
4. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406 [TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP regulates the calcium transients released from IP(3)-sensitive stores by activation of rat kappa-opioid receptors expressed in CHO cells. Ikeda M; Nelson CS; Shinagawa H; Shinoe T; Sugiyama T; Allen CN; Grandy DK; Yoshioka T Cell Calcium; 2001 Jan; 29(1):39-48. PubMed ID: 11133354 [TBL] [Abstract][Full Text] [Related]
6. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926 [TBL] [Abstract][Full Text] [Related]
7. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
8. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat. Fox DA; Burks TF J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341 [TBL] [Abstract][Full Text] [Related]
9. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192 [TBL] [Abstract][Full Text] [Related]
12. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands. de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008 [TBL] [Abstract][Full Text] [Related]
13. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line. Baumhaker Y; Wollman Y; Goldstein MN; Sarne Y Life Sci; 1993; 52(19):PL205-10. PubMed ID: 8387137 [TBL] [Abstract][Full Text] [Related]
14. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling. Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719 [TBL] [Abstract][Full Text] [Related]
15. Characterization and distribution of a cloned rat mu-opioid receptor. Bunzow JR; Zhang G; Bouvier C; Saez C; Ronnekleiv OK; Kelly MJ; Grandy DK J Neurochem; 1995 Jan; 64(1):14-24. PubMed ID: 7798908 [TBL] [Abstract][Full Text] [Related]
16. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach. Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793 [TBL] [Abstract][Full Text] [Related]
17. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
18. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Stiene-Martin A; Zhou R; Hauser KF Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]